These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 19063817

  • 21. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 22. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
    Sogutlu Sari E, Yazici A, Eser B, Erol MK, Kilic A, Ermis SS, Koytak A, Akşit H, Yakut T.
    Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892
    [Abstract] [Full Text] [Related]

  • 23. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
    Armangil D, Yurdakök M, Okur H, Gürgey A.
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):352-7. PubMed ID: 20460339
    [Abstract] [Full Text] [Related]

  • 24. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
    Yıldırım ME, Karakuş S, Kurtulgan HK, Kılıçgün H, Erşan S, Bakır S.
    Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
    [Abstract] [Full Text] [Related]

  • 25. SERPINE1 -675 4G/5G polymorphism is associated with asthma severity and inhaled corticosteroid response.
    Dijkstra A, Postma DS, Bruinenberg M, van Diemen CC, Boezen HM, Koppelman GH, Timens W, Vonk JM.
    Eur Respir J; 2011 Nov; 38(5):1036-43. PubMed ID: 21478212
    [Abstract] [Full Text] [Related]

  • 26. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 27. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE, Yuregir OO, Balli M, Tekin K, Akilli RE, Bozdogan ST, Turkmen S, Deniz A, Baykan OA, Aslan H, Cayli M.
    Coron Artery Dis; 2013 May 01; 24(3):196-200. PubMed ID: 23283030
    [Abstract] [Full Text] [Related]

  • 28. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
    Xu F, Liu H, Sun Y.
    Ren Fail; 2016 May 01; 38(1):157-62. PubMed ID: 26616527
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A, Shetty S, Ghosh K, Kulkarni B.
    Eur J Haematol; 2017 Sep 01; 99(3):249-254. PubMed ID: 28561456
    [Abstract] [Full Text] [Related]

  • 31. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D.
    Thromb Haemost; 2005 Jan 01; 93(1):92-6. PubMed ID: 15630497
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX, Du XY, Wang JX, Wang RL, Wu ZL, Jiang H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr 01; 21(2):173-5. PubMed ID: 15079805
    [Abstract] [Full Text] [Related]

  • 34. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].
    Liu SQ, Xue YM, Yang GC, He FY, Zhao XS.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug 01; 24(8):904-7. PubMed ID: 15321757
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, Saxena R.
    Clin Appl Thromb Hemost; 2010 Apr 01; 16(2):184-8. PubMed ID: 19419975
    [Abstract] [Full Text] [Related]

  • 37. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N, Ghazouani L, Saidi S, Ben-Hadj-Khalifa S, Addad F, Almawi WY, Mahjoub T.
    Genet Test Mol Biomarkers; 2010 Feb 01; 14(1):23-7. PubMed ID: 19929406
    [Abstract] [Full Text] [Related]

  • 38. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM, Ostriakova EV, Patrusheva NL, Patrushev LI, Aleksandrova EN, Seredavkina NV, Volkov AV, Nasonov EL.
    Ter Arkh; 2013 Feb 01; 85(1):76-84. PubMed ID: 23536951
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The CC16 A38G polymorphism is associated with the development of asthma in children with allergic rhinitis.
    Ku MS, Sun HL, Lu KH, Sheu JN, Lee HS, Yang SF, Lue KH.
    Clin Exp Allergy; 2011 Jun 01; 41(6):794-800. PubMed ID: 21255142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.